Newtyn Management, LLC is a New York-based investment firm founded in 2011 and run as. Organization, location and related investors we track.
Newtyn Management, LLC is a New York-based investment firm founded in 2011 and run as an SEC-registered adviser; it manages two partnerships, including Newtyn TE Partners, LP, and has been described as a hedge fund manager. Its public profile says the firm is value-oriented and generally focuses on U.S. equity securities, while also looking across the capital structure and across jurisdictions for special situations tied to restructurings, bankruptcies, liquidations, mergers, divestitures, and IPOs. Public sources do not give a standard check size, but its filings show concentrated positions and a passive 7.7% stake in Magnera Corporation, indicating it sometimes holds meaningful blocks rather than disclosing venture-style rounds. Named holdings reported in SEC-related portfolio data include Indivior, QuidelOrtho, Theravance Biopharma, United States Cellular, and Cannae Holdings, with newer positions in Magnera, GCI Liberty, CommScope, Darling Ingredients, and scPharmaceuticals. The firm also reported 33 holdings and roughly $816.9 million in disclosed 13F portfolio value in recent filings. Its public writing emphasizes a bottom-up, patient
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in New York.
Investors like Newtyn Management, LLC · Full investor directory · Investor access · Company funding database